Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Gliovac + Sargramostim |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Gliovac | ERC1671|ERC 1671|ERC-1671|Sitoiganap | Gliovac (ERC 1671) is a glioblastoma vaccine comprising autologous tumor-derived antigens and allogeneic tumor-derived antigens, which may induce an anti-tumor immune response (PMID: 25865468, PMID: 30157683). | ||
Sargramostim | Leukine | GM-CSF|Prokine |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|